Risk for Monoclonal Gammopathy of Undetermined Significance (MGUS) is age-dependent. Population studies suggest that risk relates to about: 3% > 50 years old 5% > 70 years old 7.5% > 85 years old Patients in whom serum protein EPG (SEP) detects a monoclonal gammopathy require monitoring, because up to 30% of these people will go on to … Continue reading MGUS